PL365441A1 - Związki heterocykliczne przeciwko związanymi ze starzeniem i cukrzycą powikłaniami naczyniowymi - Google Patents

Związki heterocykliczne przeciwko związanymi ze starzeniem i cukrzycą powikłaniami naczyniowymi

Info

Publication number: PL365441A1
Authority: PL; Poland
Prior art keywords: discloses; age; compounds; vascular complications; aging
Prior art date: 2001-04-05

Application number

PL02365441A

Other languages

English (en)

Inventor

Alangudi Sankaranarayanan

Original Assignee

Torrent Pharmaceuticals Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-05

Filing date

2002-04-02

Publication date

2005-01-10

2002-04-02 Application filed by Torrent Pharmaceuticals Ltd. filed Critical Torrent Pharmaceuticals Ltd.

2005-01-10 Publication of PL365441A1 publication Critical patent/PL365441A1/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Immunology (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Hematology (AREA)
Cardiology (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)

PL02365441A 2001-04-05 2002-04-02 Związki heterocykliczne przeciwko związanymi ze starzeniem i cukrzycą powikłaniami naczyniowymi PL365441A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28138001P	2001-04-05	2001-04-05
PCT/IB2002/001137 WO2002085897A1 (en)	2001-04-05	2002-04-02	Heterocyclic compounds for aging-related and diabetic vascular complications

Publications (1)

Publication Number	Publication Date
PL365441A1 true PL365441A1 (pl)	2005-01-10

Family

ID=23077044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02365441A PL365441A1 (pl)	2001-04-05	2002-04-02	Związki heterocykliczne przeciwko związanymi ze starzeniem i cukrzycą powikłaniami naczyniowymi

Country Status (22)

Country	Link
US (2)	US7223777B2 (pl)
EP (1)	EP1373263B1 (pl)
JP (2)	JP4485744B2 (pl)
KR (1)	KR100785109B1 (pl)
CN (1)	CN1259316C (pl)
AT (1)	ATE280766T1 (pl)
AU (1)	AU2002253432B2 (pl)
BR (1)	BR0208561A (pl)
CA (1)	CA2439593C (pl)
CZ (1)	CZ20032013A3 (pl)
DE (1)	DE60201740T2 (pl)
DK (1)	DK1373263T3 (pl)
ES (1)	ES2231685T3 (pl)
HK (1)	HK1061234A1 (pl)
HU (1)	HUP0400823A3 (pl)
MX (1)	MXPA03008089A (pl)
PL (1)	PL365441A1 (pl)
PT (1)	PT1373263E (pl)
RU (1)	RU2291154C2 (pl)
SI (1)	SI1373263T1 (pl)
WO (1)	WO2002085897A1 (pl)
ZA (1)	ZA200306370B (pl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1355645A4 (en) *	2000-12-29	2005-02-23	Alteon Inc	METHOD FOR THE TREATMENT OF FIBROUS OR OTHER IIIC INDICATIONS
PT1373263E (pt) *	2001-04-05	2005-03-31	Torrent Pharmaceuticals Ltd	Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas
CN100436445C (zh) *	2003-02-07	2008-11-26	第一制药株式会社	吡唑衍生物
JPWO2004069824A1 (ja)	2003-02-07	2006-05-25	第一製薬株式会社	ピラゾール誘導体
US7932272B2 (en)	2003-09-30	2011-04-26	Eisai R&D Management Co., Ltd.	Antifungal agent containing heterocyclic compound
US7354938B2 (en) *	2004-03-23	2008-04-08	Amgen Inc.	Pyrazole compounds and uses related thereto
US20050241110A1 (en) *	2004-04-09	2005-11-03	Bruce Baker	Ergonomic handles, especially for garden tools
WO2006002983A1 (en) *	2004-07-06	2006-01-12	Novartis Ag	Combination of organic compounds
JPWO2006016548A1 (ja) *	2004-08-09	2008-05-01	エーザイ・アール・アンド・ディー・マネジメント株式会社	ヘテロ環化合物を含有する新規な抗マラリア剤
EP1797072A4 (en) *	2004-09-17	2009-09-09	Exelixis Inc	PYRAZOLKINASE MODULATORS AND USE METHOD
ATE477254T1 (de)	2004-12-20	2010-08-15	Genentech Inc	Pyrrolidine als inhibitoren von iap
US20080275134A1 (en) *	2005-02-24	2008-11-06	University Of Washington	Methods for Treatment of Retinal Degenerative Disease
JP4874958B2 (ja)	2005-03-30	2012-02-15	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピリジン誘導体を含有する抗真菌剤
EP1944303B1 (en) *	2005-10-31	2013-08-21	Eisai R&D Management Co., Ltd.	Pyridine derivative substituted by heterocycle and fungicide containing the same
CN101300250B (zh) *	2005-10-31	2012-09-05	卫材R&D管理有限公司	杂环取代吡啶衍生物及含有该衍生物的抗真菌剂
TWI385169B (zh)	2005-10-31	2013-02-11	Eisai R&D Man Co Ltd	經雜環取代之吡啶衍生物及含有彼之抗真菌劑
SA07280004B1 (ar)	2006-02-02	2011-10-29	استرازينيكا ايه بي	ملح سترات من مركب 2- هيدروكسي –3- [5- (مورفولين –4- يل ميثيل) بيريدين –2- يل] 1h- إندول –5- كربونيتريل سترات
AP2009004763A0 (en) *	2006-07-05	2009-02-28	Pfizer Prod Inc	Pyrazole derivatives as cytochrome P450 inhibitors
EP2065377B1 (en)	2006-09-21	2011-11-23	Eisai R&D Management Co., Ltd.	Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
BRPI0719352A2 (pt) *	2006-11-29	2017-10-24	Abbott Lab	inibidores de enzima diacilglicerol o-aciltransferase tipo 1
US20080312169A1 (en) *	2007-03-20	2008-12-18	Clarence Albert Johnson	Cosmetic use of D-ribose
US20090197819A1 (en) *	2007-03-20	2009-08-06	Clarence Albert Johnson	Compositions for improving and repairing skin
WO2008136279A1 (ja)	2007-04-27	2008-11-13	Eisai R & D Management Co., Ltd.	ヘテロ環置換ピリジン誘導体の塩またはその結晶
TW200841879A (en)	2007-04-27	2008-11-01	Eisai R&D Man Co Ltd	Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
CL2008001234A1 (es) *	2007-04-30	2008-09-22	Genentech Inc	Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
FR2918570B1 (fr) *	2007-07-09	2012-10-05	Engelhard Lyon	DIGLYCATION DES AGEs.
EP2203162B1 (en) *	2007-09-26	2017-11-08	Indiana University Research and Technology Corporation	Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
CA2709664A1 (en)	2007-12-26	2009-07-02	Eisai R&D Management Co., Ltd.	Method for manufacturing heterocycle substituted pyridine derivatives
US8513287B2 (en)	2007-12-27	2013-08-20	Eisai R&D Management Co., Ltd.	Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
KR100989093B1 (ko)	2008-01-18	2010-10-25	한화제약주식회사	생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
JP2011510067A (ja) *	2008-01-25	2011-03-31	トレント・ファーマシューティカルズ・リミテッド	組合せ医薬品
US20090232750A1 (en) *	2008-03-13	2009-09-17	St Cyr John A	Compositions for indoor tanning
NZ590550A (en)	2008-08-02	2013-05-31	Genentech Inc	Inhibitors of Apoptosis (IAP) for treating cancer
WO2010032874A1 (ja) *	2008-09-19	2010-03-25	住友化学株式会社	農業用組成物
US8697689B2 (en) *	2008-10-16	2014-04-15	Janssen Pharmaceuticals, Inc.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8188119B2 (en)	2008-10-24	2012-05-29	Eisai R&D Management Co., Ltd	Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
TW201102380A (en)	2009-05-07	2011-01-16	Torrent Pharmaceuticals Ltd	Novel heterocyclic compounds
KR101040162B1 (ko) *	2009-05-12	2011-06-09	주식회사 카모스	감시카메라의 브라켓
WO2011051198A2 (de)	2009-10-30	2011-05-05	Bayer Cropscience Ag	Pyridin-derivate als pflanzenschutzmittel
KR101018881B1 (ko) *	2009-11-03	2011-03-04	주식회사 엑스트론아이앤티	감시카메라용 브라켓
WO2011136318A1 (ja) *	2010-04-28	2011-11-03	東レ株式会社	アルツハイマー病の治療剤又は予防剤
WO2012020738A1 (ja) *	2010-08-09	2012-02-16	武田薬品工業株式会社	複素環化合物およびその用途
US9533976B2 (en)	2013-02-22	2017-01-03	Samumed, Llc	γ-diketones as WNT/β-catenin signaling pathway activators
US9226890B1 (en)	2013-12-10	2016-01-05	Englewood Lab, Llc	Polysilicone base for scar treatment
KR101898364B1 (ko) *	2014-05-22	2018-09-12	에프. 호프만-라 로슈 아게	인돌린-2-온 및 1,3-다이하이드로-피롤로[3,2-c]피리딘-2-온 유도체
KR102165385B1 (ko)	2014-08-20	2020-10-15	사뮤메드, 엘엘씨	피부 노화 및 주름의 치료 및 예방을 위한 감마-디케톤
FR3026947B1 (fr) *	2014-10-10	2017-12-08	Basf Beauty Care Solutions France Sas	Activite deglycation d'une combinaison d'un extrait de salvia miltiorrhiza et de niacine et/ou de niacinamide
SG11201708140RA (en)	2015-04-08	2017-11-29	Torrent Pharmaceuticals Ltd	Novel pyridinium compounds
CN106806886B (zh) *	2015-12-01	2021-07-16	华中科技大学	一种快速消除口臭的口气清新剂及其医药用途
BR112020011162A2 (pt)	2017-12-07	2020-11-17	Amplyx Pharmaceuticals, Inc.	agentes antifúngicos derivados de piridina substituída por heterociclo
CN108157405B (zh) *	2018-02-06	2020-10-02	上海应用技术大学	一种灭蟑螂饵剂及其制备方法和应用
CA3104653A1 (en)	2018-06-25	2020-01-02	Amplyx Pharmaceuticals, Inc.	Pyridine derivatives substituted by heterocyclic ring and amino group
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE
DE202022104072U1 (de)	2022-07-19	2022-07-29	Siva Subramanian Narayanasamy	Heterozyklisch substituierte pyridinderivate antimykotische Mittel

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3501484A (en) *	1968-01-15	1970-03-17	Miles Lab	Certain substituted 3 - (2-indolyl)-1,2,5,6-tetrahydropyridines and derivatives thereof
US3501312A (en) *	1968-07-22	1970-03-17	Eastman Kodak Co	Direct positive silver halide emulsions containing trimethine cyanine dyes
US3957805A (en) *	1974-07-24	1976-05-18	American Cyanamid Company	Substituted pyridines and diazines and methods of preparing the same
US4758583A (en)	1984-03-19	1988-07-19	The Rockefeller University	Method and agents for inhibiting protein aging
US5137916A (en)	1985-11-14	1992-08-11	The Rockefeller University	Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
US5272176A (en)	1984-03-19	1993-12-21	The Rockefeller University	Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
US5514676A (en)	1984-03-19	1996-05-07	The Rockefeller University	Amino-benzoic acids and derivatives, and methods of use
GB8714789D0 (en) *	1987-06-24	1987-07-29	Lundbeck & Co As H	Heterocyclic compounds
EP0339496A3 (en)	1988-04-26	1991-05-08	Ono Pharmaceutical Co., Ltd.	Aminoguanidine derivatives
US5330994A (en) *	1992-03-24	1994-07-19	Warner-Lambert Company	Tetrahydropyridine isoxazoline derivatives
DE4210502A1 (de) *	1992-03-31	1993-10-07	Bayer Ag	Verwendung von 3-aminosubstituierten Isoxazolderivaten zur Bekämpfung von Endoparasiten, neue 3-aminosubstituierte Isoxazolderivate und Verfahren zu ihrer Herstellung
US5656261A (en)	1995-01-18	1997-08-12	The Picower Institute For Medical Research	Preventing and reversing advanced glycosylation endproducts
US5853703A (en)	1995-01-18	1998-12-29	The Picower Institute For Medical Research	Preventing and reversing the formation of advanced glycosylation endproducts
US6228858B1 (en) *	1995-09-12	2001-05-08	University Of Kansas Medical Center	Advanced glycation end-product intermediaries and post-amadori inhibition
JPH09291082A (ja) *	1996-02-27	1997-11-11	Sankyo Co Ltd	イソキサゾール誘導体
WO1998056785A1 (fr) *	1997-06-12	1998-12-17	Sumitomo Pharmaceuticals Co., Ltd.	Derives de pyrazole
US6342500B1 (en) *	1999-03-05	2002-01-29	Kansas University Medical Center	Post-Amadori inhibitors of Advanced Glycation reactions
US20010044445A1 (en) *	1999-04-08	2001-11-22	Bamaung Nwe Y.	Azole inhibitors of cytokine production
AU4671100A (en) *	1999-04-30	2000-11-17	City Of Hope	Method of inhibiting glycation product formation
FR2796278B1 (fr)	1999-07-16	2002-05-03	Oreal	Utilisation d'au moins un hydroxystilbene comme agent anti-glycation
DK1222171T3 (da) *	1999-10-06	2004-07-05	Torrent Pharmaceuticals Ltd	Pyridiniumderivater, til regulering af aldersrelaterede og diabetesvaskulære komplikationer, fremgangsmåde til fremstilling af disse samt terapeutiske anvendelser deraf
BR9915962A (pt) *	1999-10-06	2003-01-07	Torrent Pharmaceuticals Ltd	Composto da série do piridìnio, processos para a preparação de composto da série do piridìnio e de uma formulação parenteral, uso de um composto, composição farmacêutica para tratar complicações diabéticas e doenças associadas ao envelhecimento, e, método para tratar um paciente diabético e para prevenir ou tratar doenças causadas por complicações associadas à diabetes e ao envelhecimento
FR2802420B1 (fr)	1999-12-21	2002-02-22	Oreal	Utilisation du 3,3', 5,5'-tetrahydroxystilbene comme agent anti-glycation
PT1373263E (pt) *	2001-04-05	2005-03-31	Torrent Pharmaceuticals Ltd	Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas

2002
- 2002-04-02 PT PT02722547T patent/PT1373263E/pt unknown
- 2002-04-02 EP EP02722547A patent/EP1373263B1/en not_active Expired - Lifetime
- 2002-04-02 AU AU2002253432A patent/AU2002253432B2/en not_active Ceased
- 2002-04-02 JP JP2002583424A patent/JP4485744B2/ja not_active Expired - Fee Related
- 2002-04-02 SI SI200230069T patent/SI1373263T1/xx unknown
- 2002-04-02 DE DE60201740T patent/DE60201740T2/de not_active Expired - Lifetime
- 2002-04-02 RU RU2003128076/04A patent/RU2291154C2/ru not_active IP Right Cessation
- 2002-04-02 CA CA2439593A patent/CA2439593C/en not_active Expired - Fee Related
- 2002-04-02 DK DK02722547T patent/DK1373263T3/da active
- 2002-04-02 WO PCT/IB2002/001137 patent/WO2002085897A1/en active IP Right Grant
- 2002-04-02 HU HU0400823A patent/HUP0400823A3/hu unknown
- 2002-04-02 BR BR0208561-5A patent/BR0208561A/pt not_active IP Right Cessation
- 2002-04-02 CN CNB028069803A patent/CN1259316C/zh not_active Expired - Fee Related
- 2002-04-02 ES ES02722547T patent/ES2231685T3/es not_active Expired - Lifetime
- 2002-04-02 AT AT02722547T patent/ATE280766T1/de not_active IP Right Cessation
- 2002-04-02 PL PL02365441A patent/PL365441A1/pl not_active Application Discontinuation
- 2002-04-02 KR KR1020037012877A patent/KR100785109B1/ko not_active IP Right Cessation
- 2002-04-02 MX MXPA03008089A patent/MXPA03008089A/es active IP Right Grant
- 2002-04-02 CZ CZ20032013A patent/CZ20032013A3/cs unknown
- 2002-04-05 US US10/116,135 patent/US7223777B2/en not_active Expired - Fee Related
2003
- 2003-08-15 ZA ZA200306370A patent/ZA200306370B/en unknown
2004
- 2004-06-11 HK HK04104243A patent/HK1061234A1/xx not_active IP Right Cessation
2007
- 2007-03-29 US US11/727,909 patent/US20070167493A1/en not_active Abandoned
2009
- 2009-12-25 JP JP2009295336A patent/JP2010100640A/ja active Pending

Also Published As

Publication number	Publication date
HUP0400823A2 (hu)	2004-07-28
AU2002253432B2 (en)	2005-03-24
DE60201740D1 (de)	2004-12-02
JP4485744B2 (ja)	2010-06-23
US7223777B2 (en)	2007-05-29
KR20030086340A (ko)	2003-11-07
EP1373263A1 (en)	2004-01-02
WO2002085897A9 (en)	2004-04-01
EP1373263B1 (en)	2004-10-27
DE60201740T2 (de)	2005-11-03
HUP0400823A3 (en)	2010-06-28
PT1373263E (pt)	2005-03-31
WO2002085897A1 (en)	2002-10-31
CN1259316C (zh)	2006-06-14
CA2439593C (en)	2010-02-09
RU2291154C2 (ru)	2007-01-10
HK1061234A1 (en)	2004-09-10
JP2010100640A (ja)	2010-05-06
CN1498217A (zh)	2004-05-19
MXPA03008089A (es)	2004-01-22
ZA200306370B (en)	2004-06-07
US20070167493A1 (en)	2007-07-19
CZ20032013A3 (cs)	2003-12-17
ES2231685T3 (es)	2005-05-16
KR100785109B1 (ko)	2007-12-12
CA2439593A1 (en)	2002-10-31
BR0208561A (pt)	2004-03-30
US20030045554A1 (en)	2003-03-06
JP2004529154A (ja)	2004-09-24
DK1373263T3 (da)	2005-03-07
ATE280766T1 (de)	2004-11-15
RU2003128076A (ru)	2005-04-10
WO2002085897A8 (en)	2002-11-28
SI1373263T1 (en)	2005-04-30

Publication	Publication Date	Title
HK1061234A1 (en)	2004-09-10	Heterocyclic compounds for aging-related and diabetic vascular complications.
NO20062256L (no)	2006-06-06	Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
NO20062335L (no)	2006-07-19	Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
UA74346C2 (uk)	2005-12-15	Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
NO20041041L (no)	2004-04-21	Fenetanolaminderivater for behandling av respiratoriske sykdommer
NO20051600L (no)	2005-06-13	1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
BRPI0415437A (pt)	2006-12-05	composto, processo para a preparação e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, produto
BR0309343A (pt)	2005-02-15	Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
NO20053748L (no)	2005-10-07	Pyrrolopyridazinderivater.
BR0309342A (pt)	2005-02-15	Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
UA83233C2 (ru)	2008-06-25	Замещенный 2-аминотетралин для лечения депрессии
NZ536750A (en)	2007-02-23	7-Aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
NO20056030L (no)	2006-02-15	Nye pyridopyraziner og anvendelse derav som kinaseinhibitorer
WO2005037798A3 (en)	2005-06-16	Amide or thiomide derivatives and their use in the treatment of pain
IT1251166B (it)	1995-05-04	Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
AU1185801A (en)	2001-05-08	Novel compounds
NO20052182L (no)	2005-05-03	Nye forbindelser
NO20060733L (no)	2006-04-10	Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommer
ATE367390T1 (de)	2007-08-15	Phenylalanin enamidderivate
DE59904875D1 (de)	2003-05-08	Substituierte phenyl-alkenoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikamente oder diagnostika sowie sie enthaltende medikamente
ATE422892T1 (de)	2009-03-15	Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
NO20026081L (no)	2003-02-04	Nye forbindelser
WO2002055491A3 (en)	2003-01-23	1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
WO2023150790A3 (en)	2023-10-26	Novel and highly selective sars-cov-2 mpro inhibitors
HRP20050667A2 (en)	2006-09-30	Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof

Legal Events

Date	Code	Title	Description
2012-09-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)